<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Development of chewable tablet formulations for cetirizine HCI, levocetirizine HCI, loratadine &amp; domperidone using polysucralose as sweetening agent</title>
  </titleInfo>
  <name type="personal">
    <namePart>Rashid Mahmood (12064)</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="text">Lahore</placeTerm>
    </place>
    <publisher>(Unpublished)</publisher>
    <dateIssued>2016</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <physicalDescription>
    <extent>viii, 87 p. : ill. (col.)  ; 29 cm. + CD</extent>
  </physicalDescription>
  <note>Submitted in fulfillment of the requirements for the degree of  Master of Philosophy to the Riphah institute of Pharmaceutical Sciences</note>
  <note>Includes bibliographical references </note>
  <note>Thesis supervisor: Dr. Muhammad Farhan Sohail </note>
  <note>English</note>
  <subject>
    <topic> Pharmaceutical Sciences Pharmacology</topic>
    <topic>Chewable tablet</topic>
    <topic>Drug formulation</topic>
    <topic>Cetirizine HCI</topic>
    <topic>Domperidone</topic>
    <topic>Loratadine</topic>
    <topic>RIPS</topic>
  </subject>
  <classification authority="ddc">615.1 RAS</classification>
  <recordInfo>
    <recordContentSource authority="marcorg"/>
  </recordInfo>
</mods>
